tetano
Editor, Senior Moderator
Cureus
. 2022 Mar 7;14(3):e22911.
doi: 10.7759/cureus.22911. eCollection 2022 Mar.
A Case of Recurrent Acute Anterior Uveitis After the Administration of COVID-19 Vaccine
Manal A Alhamazani[SUP] 1 [/SUP], Wejdan S Alruwaili[SUP] 1 [/SUP], Bandar Alshammri[SUP] 1 [/SUP], Sarah Alrashidi[SUP] 1 [/SUP], Jluwi Almasaud[SUP] 1 [/SUP]
Affiliations
Abstract
We present a case of a 37-year-old healthy man who developed acute anterior uveitis after receiving the first and second doses of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. To the best of our knowledge, this is the first report of a recurring incidence of ocular side effects associated with COVID-19 immunization. Based on the timing of the start of symptoms with the first and second vaccinations, the absence of prior medical conditions, and unremarkable investigations, we believe that the patient's anterior uveitis may have been induced by the vaccine itself. This case suggests that vaccination could be a risk factor in uveitis development and recurrence following redosing. As a result, we recommend that ophthalmologists investigate the recent immunization status in each case of uveitis with a temporal association with COVID-19 vaccine administration and record these cases to improve the quality of data tracking of potential adverse responses to vaccines.
Keywords: coronavirus; covid-19 infection; ocular manifestation; uveitis; vaccination.
. 2022 Mar 7;14(3):e22911.
doi: 10.7759/cureus.22911. eCollection 2022 Mar.
A Case of Recurrent Acute Anterior Uveitis After the Administration of COVID-19 Vaccine
Manal A Alhamazani[SUP] 1 [/SUP], Wejdan S Alruwaili[SUP] 1 [/SUP], Bandar Alshammri[SUP] 1 [/SUP], Sarah Alrashidi[SUP] 1 [/SUP], Jluwi Almasaud[SUP] 1 [/SUP]
Affiliations
- PMID: 35399463
- PMCID: PMC8986516
- DOI: 10.7759/cureus.22911
Abstract
We present a case of a 37-year-old healthy man who developed acute anterior uveitis after receiving the first and second doses of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. To the best of our knowledge, this is the first report of a recurring incidence of ocular side effects associated with COVID-19 immunization. Based on the timing of the start of symptoms with the first and second vaccinations, the absence of prior medical conditions, and unremarkable investigations, we believe that the patient's anterior uveitis may have been induced by the vaccine itself. This case suggests that vaccination could be a risk factor in uveitis development and recurrence following redosing. As a result, we recommend that ophthalmologists investigate the recent immunization status in each case of uveitis with a temporal association with COVID-19 vaccine administration and record these cases to improve the quality of data tracking of potential adverse responses to vaccines.
Keywords: coronavirus; covid-19 infection; ocular manifestation; uveitis; vaccination.